ArticleOncogene2014

Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.

C Barckhausen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.